GB201522179D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB201522179D0 GB201522179D0 GBGB1522179.9A GB201522179A GB201522179D0 GB 201522179 D0 GB201522179 D0 GB 201522179D0 GB 201522179 A GB201522179 A GB 201522179A GB 201522179 D0 GB201522179 D0 GB 201522179D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522179.9A GB201522179D0 (en) | 2015-12-16 | 2015-12-16 | Novel compounds |
| PCT/GB2016/053958 WO2017103604A1 (en) | 2015-12-16 | 2016-12-16 | Hydantoin modulators of kv3 channels |
| BR112018012177A BR112018012177A2 (pt) | 2015-12-16 | 2016-12-16 | ?moduladores de hidantação de canais kv 3? |
| JP2018531529A JP7036725B2 (ja) | 2015-12-16 | 2016-12-16 | Kv3チャネルのヒダントインモジュレーター |
| CN201680074553.9A CN108430995A (zh) | 2015-12-16 | 2016-12-16 | 新型化合物 |
| US16/061,557 US20200377485A1 (en) | 2015-12-16 | 2016-12-16 | Hydantoin modulators of kv3 channels |
| EP16816359.0A EP3390394B1 (en) | 2015-12-16 | 2016-12-16 | Hydantoin modulators of kv3 channels |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1522179.9A GB201522179D0 (en) | 2015-12-16 | 2015-12-16 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201522179D0 true GB201522179D0 (en) | 2016-01-27 |
Family
ID=55274838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1522179.9A Ceased GB201522179D0 (en) | 2015-12-16 | 2015-12-16 | Novel compounds |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20200377485A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3390394B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7036725B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN108430995A (cg-RX-API-DMAC7.html) |
| BR (1) | BR112018012177A2 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201522179D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2017103604A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201521751D0 (en) | 2015-12-10 | 2016-01-27 | Autifony Therapeutics Ltd | Novel uses |
| GB201613163D0 (en) | 2016-07-29 | 2016-09-14 | Autifony Therapeutics Ltd | Novel compounds |
| US20200039970A1 (en) | 2016-12-16 | 2020-02-06 | Autifony Therapeutics Limited | Hydantoin modulators of kv3 channels |
| PL3867247T3 (pl) | 2018-10-16 | 2024-12-09 | Autifony Therapeutics Limited | Nowe związki |
| US12358901B2 (en) | 2018-10-16 | 2025-07-15 | Autifony Therapeutics Limited | KV3 modulators |
| US20200131156A1 (en) * | 2018-10-30 | 2020-04-30 | H. Lundbeck A/S | ARYLSULFONYLPYROLECARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS |
| US20220220095A1 (en) | 2019-04-26 | 2022-07-14 | H. Lundbeck A/S | N-((HETEROARYL)METHYL)-1-TOSYL-1H-PYRAZOLE-3-CARBOXAMIDE DERIVATIVES AS Kv3 POTASSIUM CHANNEL ACTIVATORS FOR TREATING NEUROLOGICAL AND PSYCHIATRIC DISORDERS |
| CN113710318A (zh) | 2019-04-26 | 2021-11-26 | H.隆德贝克有限公司 | 作为Kv3钾通道激活剂的芳基磺酰基噻吩甲酰胺和芳基磺酰基呋喃甲酰胺 |
| BR112022013339A2 (pt) | 2020-02-06 | 2022-09-13 | Autifony Therapeutics Ltd | Moduladores de kv3 |
| EP3901152A1 (en) * | 2020-04-23 | 2021-10-27 | F. Hoffmann-La Roche AG | Kv3 enhancers for the treatment of cognitive disorders |
| CA3226856A1 (en) | 2021-08-10 | 2023-02-16 | Autifony Therapeutics Limited | Potassium channel modulators |
| EP4630117A1 (en) | 2022-12-06 | 2025-10-15 | Autifony Therapeutics Limited | Compounds for the treatment of centra nervous system disorders |
| WO2026093398A1 (en) | 2024-10-29 | 2026-05-07 | Autifony Therapeutics Limited | Kv3 modulators for use in the treatment or prophylaxis of amyotrophic lateral sclerosis (als) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6299383A (ja) * | 1985-10-28 | 1987-05-08 | Tokuyama Soda Co Ltd | エ−テル化合物の製造方法 |
| KR20050033663A (ko) * | 2002-09-05 | 2005-04-12 | 메디비르 아베 | 비-뉴클레오시드 역전사효소 억제제 |
| US20050080100A1 (en) * | 2003-10-09 | 2005-04-14 | Pfizer Inc | Pyridylamino compounds and methods of use thereof |
| EP1845087A1 (en) * | 2006-04-14 | 2007-10-17 | Mutabilis SA | Hydroxyphenyl derivatives and biological applications thereof |
| JP6112486B2 (ja) * | 2010-04-27 | 2017-04-12 | カルシメディカ,インク. | 細胞内カルシウムを調節する化合物 |
| KR101862375B1 (ko) * | 2010-12-06 | 2018-05-29 | 오티포니 세라피틱스 리미티드 | Kv3 억제제로서 유용한 하이단토인 유도체 |
| WO2012170931A2 (en) * | 2011-06-10 | 2012-12-13 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US9273054B2 (en) * | 2011-07-27 | 2016-03-01 | Glaxo Group Limited | Substituted pyrimido[1,6-a]pyrimidines as Lp-PLA2 inhibitors |
| JP2015517563A (ja) * | 2012-05-22 | 2015-06-22 | アウトイフオンイ トヘラペウトイクス リミテッド | Kv3阻害剤としてのヒダントイン誘導体 |
| JP6226967B2 (ja) * | 2012-06-06 | 2017-11-08 | ヴァンダービルト ケミカルズ、エルエルシー | 燃費効率がよい潤滑油 |
| WO2013182851A1 (en) * | 2012-06-06 | 2013-12-12 | Autifony Therapeutics Limited | Prophylaxis or treatment of diseases where a modulator of kv3.3 channels is required |
| WO2015031036A1 (en) * | 2013-08-26 | 2015-03-05 | Purdue Pharma L.P. | Azaspiro[4.5] decane derivatives and use thereof |
-
2015
- 2015-12-16 GB GBGB1522179.9A patent/GB201522179D0/en not_active Ceased
-
2016
- 2016-12-16 EP EP16816359.0A patent/EP3390394B1/en not_active Not-in-force
- 2016-12-16 US US16/061,557 patent/US20200377485A1/en not_active Abandoned
- 2016-12-16 CN CN201680074553.9A patent/CN108430995A/zh active Pending
- 2016-12-16 BR BR112018012177A patent/BR112018012177A2/pt not_active IP Right Cessation
- 2016-12-16 JP JP2018531529A patent/JP7036725B2/ja not_active Expired - Fee Related
- 2016-12-16 WO PCT/GB2016/053958 patent/WO2017103604A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20200377485A1 (en) | 2020-12-03 |
| EP3390394B1 (en) | 2022-05-25 |
| CN108430995A (zh) | 2018-08-21 |
| JP7036725B2 (ja) | 2022-03-15 |
| BR112018012177A2 (pt) | 2018-11-27 |
| JP2019502696A (ja) | 2019-01-31 |
| EP3390394A1 (en) | 2018-10-24 |
| WO2017103604A1 (en) | 2017-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201804739B (en) | Novel compounds | |
| IL255067A0 (en) | new compounds | |
| GB201516243D0 (en) | Novel compounds | |
| GB201522768D0 (en) | Novel compounds | |
| GB201521109D0 (en) | Novel compounds | |
| GB201506871D0 (en) | Novel compounds | |
| GB201501462D0 (en) | Novel compounds | |
| GB201510019D0 (en) | Compounds | |
| GB201504565D0 (en) | Novel compounds | |
| GB201514754D0 (en) | Compounds | |
| GB201508747D0 (en) | Compounds | |
| GB201514751D0 (en) | Compounds | |
| GB201510493D0 (en) | Compounds | |
| GB201508864D0 (en) | Compounds | |
| GB201502675D0 (en) | Novel compounds | |
| GB201503926D0 (en) | Compounds | |
| GB201501115D0 (en) | Compounds | |
| GB201508857D0 (en) | Compounds | |
| GB201521749D0 (en) | Novel compounds | |
| GB201521713D0 (en) | Novel compounds | |
| GB201516241D0 (en) | Novel compounds | |
| GB201512829D0 (en) | Novel compounds | |
| GB201512270D0 (en) | Novel Compounds | |
| GB201511842D0 (en) | Novel compounds | |
| GB201510191D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |